Monday, June 15, 2026

Bundibugyo Ebola Outbreak Triggers WHO Emergency Declaration and Heightened South Korean Response Measures

WHO declares a Public Health Emergency of International Concern over Ebola outbreak in the Democratic Republic of Congo, raising global tensions.

THE UNSEEN DOOMSDAY: Kim Unveils Secret “Invisible” Nukes Targeted At The Heart Of America!

Kim Jong Un plans to enhance North Korea's nuclear arsenal and develop new weapons, focusing on threats to South Korea and the U.S.

LA Dodgers’ Shohei Ohtani Hits His 24th Home Run of the Season!

Major League Superstar Shohei Ohtani of the...

Tag: Growth

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Onconic Therapeutics Expands Zaqbo Development in China With Phase 3 Trial for H. pylori Eradication

Onconic Therapeutics' Zaqbo enters Phase 3 trials in China for H. pylori eradication, with strong revenue growth reported.

Researchers Identify Bone Age Differences Between Limbs in Rare Pediatric Overgrowth Disorders

A study reveals children with congenital hemihypertrophy show differing bone maturation rates, impacting surgical planning for limb discrepancies.

HLB Genex Advances U.S. Market Entry With First Catalase Supply for Semiconductor Manufacturing

HLB Genex has launched catalase shipments to the U.S. semiconductor market, aiming for long-term growth and capitalizing on global demand.

Hanmi Semiconductor to Launch Hanmi USA in Silicon Valley as It Expands U.S. AI Chip Presence

Hanmi Semiconductor plans to launch a U.S. subsidiary in Silicon Valley to meet AI semiconductor demand and enhance global collaboration.

U.S., Japan and China Advance Stem Cell Commercialization While Korea Works to Close Gaps

The global stem cell therapy market is rapidly growing, but South Korea faces challenges in commercialization compared to the U.S. and Japan.

Novo Nordisk’s Weekly Growth Hormone Sogroya Gains Reimbursement in Korea

Novo Nordisk's Sogroya gains insurance coverage, but market changes may be limited due to strong competitors and safety concerns.

PharmaResearch Posts Near-40% Operating Margin as Rejuran and Medical Aesthetics Drive Growth

PharmaResearch reports a 39.2% operating profit margin, driven by strong sales in medical aesthetics and cosmetics, despite market competition.

Novo Nordisk’s Oral Wegovy Just Put Up a Number That Could Change the Obesity Drug Race

Novo Nordisk's oral obesity treatment, Wegovy, saw $400M in Q1 2026 sales, exceeding estimates and indicating strong market demand.

Celltrion’s Zymfentra Just Hit a New U.S. Prescription Record and the Growth Looks Serious

Celltrion's Zymfentra treatment saw a 185% surge in U.S. prescriptions, driven by effective marketing and reimbursement strategies.

Samsung vs Apple: Who Will Dominate the Smart Glasses Market?

Competition in the smart glasses market is heating up, with Samsung and Apple poised to launch innovative products soon.

Angel Robotics blurs line between healthcare and industry with wearable robots

Angel Robotics is enhancing rehabilitation and industrial safety with wearable robots, targeting gait assistance and reducing musculoskeletal disorders.

Coreline Soft’s SaaS Shift: How AI is Transforming Medical Imaging in Europe and Asia

Coreline Soft shifts to a SaaS model, expanding into the European market, enhancing revenue stability, and focusing on policy integration.

D&D Pharmatech signs $1.24 million obesity drug research deal with Pfizer

D&D Pharmatech partners with Pfizer for a $1.24M obesity treatment project, marking a significant revenue milestone for the company.

2026 PRP Kit Revolution: How Humedix and Medisarang Are Transforming Regenerative Medicine

Humedics and Medisarang partner to develop regenerative medicine devices, focusing on PRP kits for aesthetics and other medical fields.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.